Related references
Note: Only part of the references are listed.Targeting DNA repair mechanisms in cancer
John M. Furgason et al.
PHARMACOLOGY & THERAPEUTICS (2013)
An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
Mrinal Srivastava et al.
CELL (2012)
Targeting the DNA damage response in oncology: past, present and future perspectives
Bristi Basu et al.
CURRENT OPINION IN ONCOLOGY (2012)
Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity
Matthew C. Smith et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2012)
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
Joanne M. Munck et al.
MOLECULAR CANCER THERAPEUTICS (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Synthetic lethality: exploiting the addiction of cancer to DNA repair
Montaser Shaheen et al.
BLOOD (2011)
Mycobacterium tuberculosis Ku can bind to nuclear DNA damage and sensitize mammalian cells to bleomycin sulfate
Reneau Castore et al.
MUTAGENESIS (2011)
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons
Veerle Vandersickel et al.
RADIATION ONCOLOGY (2010)
Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance
Yongjian Zhu et al.
CANCER TREATMENT REVIEWS (2009)
Structural and Functional Interaction between the Human DNA Repair Proteins DNA Ligase IV and XRCC4
Pei-Yu Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Guido Frosina
MOLECULAR CANCER RESEARCH (2009)
Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair
Xi Chen et al.
CANCER RESEARCH (2008)
The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing rad51 expression in a p53-dependent manner
Grazia Arnbrosini et al.
CANCER RESEARCH (2008)
Down regulation of BRCA2 causes radio-sensitization of human tumor cells in vitro and in vivo
Dong Yu et al.
CANCER SCIENCE (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
Homologous recombination and prostate cancer: A model for novel DNA repair targets and therapies
Robert G. Bristow et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao et al.
CANCER RESEARCH (2006)
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer
S Madhusudan et al.
CANCER TREATMENT REVIEWS (2005)
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach
IR Hardcastle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
DNA repair inhibition: a selective tumour targeting strategy
S Madhusudan et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein
KR Jones et al.
MOLECULAR CANCER THERAPEUTICS (2005)
DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs
ET Shinohara et al.
CANCER RESEARCH (2005)
Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and γ radiation
IS Ayene et al.
MOLECULAR CANCER THERAPEUTICS (2005)
SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization
IH Ismail et al.
ONCOGENE (2004)
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
E Willmore et al.
BLOOD (2004)
Tetramerization and DNA ligase IV interaction of the DNA double-strand break repair protein XRCC4 are mutually exclusive
M Modesti et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer
LT Hansen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Crystal structure of an Xrcc4-DNA ligase IV complex
BL Sibanda et al.
NATURE STRUCTURAL BIOLOGY (2001)
Share Paper
